[Biochemical mechanism of the radioprotective action of adenylic compounds].
D000227:Adenine Nucleotides / Q000378:metabolism* / Q000627:therapeutic use; D000241:Adenosine / Q000378:metabolism; D000244:Adenosine Diphosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000031:analogs & derivatives / Q000378:metabolism; D000818:Animals; D002869:Chromosome Aberrations; D000242:Cyclic AMP / Q000378:metabolism; D004247:DNA / Q000528:radiation effects; D003852:Deoxyribonucleoproteins / Q000528:radiation effects; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D006801:Humans; D011833:Radiation Injuries, Experimental / Q000378:metabolism; D011837:Radiation-Protective Agents / Q000378:metabolism* / Q000627:therapeutic use; D013045:Species Specificity; D000338:beta-Aminoethyl Isothiourea / Q000031:analogs & derivatives / Q000378:metabolism
D000227:Adenine Nucleotides; D003852:Deoxyribonucleoproteins; D004338:Drug Combinations; D011837:Radiation-Protective Agents; D000338:beta-Aminoethyl Isothiourea; D000244:Adenosine Diphosphate; C012704:Adeturon; D000255:Adenosine Triphosphate; D004247:DNA; D000242:Cyclic AMP; D000241:Adenosine
O biokhimicheskom mekhanizme protivoluchevogo deĭstviia adenilovykh soedineniĭ.